DASATINIB
- Product NDC
- 72603-927
- 11-digit product format
- 726030927
- Labeler code
- 72603
- Product ID
- 72603-927_f9b79d54-9bee-4c93-9c87-f3e65d91f146
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DASATINIB
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA216261
- Marketing category
- ANDA
- Marketing start
- 2026-05-25
- Substance
- DASATINIB
- Active strength
- 140 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DASATINIB
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DASATINIB | 140 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | RBZ1571X5H |
| Rxcui | 643105, 643107, 643109, 799047, 1045402, 1045406 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72603-927-01 | DASATINIB | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 72603-927-01 | 72603092701 | 30 TABLET, FILM COATED in 1 BOTTLE (72603-927-01) | 2026-05-25 | No | No | Current |